NEW YORK (GenomeWeb News) – Progenika Biopharma has named Richard Lussier to the posts of chief operating officer and general manager. Ignacio Martinez has been tapped as chief financial officer and Duncan Whitney is the new chief scientific officer.
Lussier spent 13 years at Applera in marketing and management with Applied Biosystems and Celera Genomics, and he recently worked with Solexa and Illumina.
Martinez started at Progenika in Spain as CFO in 2005, and he previously was involved in high tech and biotech venture capital investing.
Whitney formerly was VP of research and development at US Genomics and was VP of technology development at Exact Sciences.
Synthetic Genomics has appointed Chuck McBride to take on the duties of executive VP and CFO as of February 12. McBride most recently was executive VP and CFO of Capstone Turbine, and he previously was executive VP and CFO at First Consulting Group.
Stephen Gomez will join Biomoda as senior research specialist and will work on the company’s lung cancer diagnostic program.
Gomez formerly was a researcher at the Lovelace Respiratory Research Institute and was a professor at the University of New Mexico.
Melodie Domurad, former Matritech VP of clinical, regulatory, and quality affairs, has joined the medical device company BioSphere, which develops microspheres for use in treatment of uterine fibroids and vascular malformations.
Enzo BioChem has named Christine Fischette president of its Enzo Therapeutics subsidiary.
Fischette formerly worked at Novartis Pharmaceuticals as executive director of global business development and licensing and head of negotiation for the company’s general business franchise board. She also spent 12 years at Pfizer and was a senior research scientist at Hoffman-La Roche.
Johns Hopkins University professor Victor McKusick was awarded the Japan Prize in Medical Genetics and Genomics, and will collect the $465,000 purse that goes along with the honor.
McKusick published the first edition of the Mendelian Inheritance in Man, a compendium of inherited disorders, in 1966. He will receive his award in Tokyo on April 23.
Transgenomic has formed its scientific advisory board. The SAB’s initial members include Christopher Corless from the Oregon Health & Science University; Pasi Janne of the Dana Farber Cancer Institute; Robert Naviaux of the University of California San Diego; Bruce Cohen of the Cleveland Clinic; and Keshav Singh of the Roswell Park Cancer Institute.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.